Stock BIOSTEM TECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Biostem Technologies Inc Stock

Equities

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Biostem Technologies Inc
05-14 Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M MT
2023 NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Latest news about Biostem Technologies Inc

Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M MT
NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT
More news

Press releases Biostem Technologies Inc

BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million AQ
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 AQ
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent AQ
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts AQ
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase AQ
More press releases

Managers and Directors - Biostem Technologies Inc

Managers TitleAgeSince
Andrew van Vurst FOU
 Founder - 06-07-06
Jason Matuszewski CEO
 Chief Executive Officer - 06-07-06
Michael Fortunato DFI
 Director of Finance/CFO - 20-12-31
Members of the board TitleAgeSince
Thomas Dugan CHM
 Chairman 66 12-12
Patrick Daly BRD
 Director/Board Member - 12-18
Jason Matuszewski CEO
 Chief Executive Officer - 06-07-06
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+7.48% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.33% 106B
BIONTECH SE Stock BioNTech SE
-12.32% 22.24B
ARGENX SE Stock argenx SE
+0.44% 21.25B
GENMAB A/S Stock Genmab A/S
-4.18% 18.97B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.85% 18.52B
BEIGENE, LTD. Stock BeiGene, Ltd.
-9.07% 16.81B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+38.50% 12.54B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-24.30% 8.09B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW